Related Experiment Video
Updated: Jul 5, 2026
09:47
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Something new about ketamine for pediatric anesthesia?
1Department of Anesthesia, Catholic University of Louvain, Brussels, Belgium.
Current Opinion in Anaesthesiology
|May 7, 2008
Summary
Ketamine is a valuable anesthetic for high-risk pediatric patients, offering benefits against pain and inflammation. However, its potential neurodevelopmental effects require further investigation in children.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Neuroscience
Background:
- Ketamine, an older anesthetic, remains relevant in pediatric anesthesia.
- Its use is common for high-risk children and non-operating room procedures.
- Adult anesthesia sees renewed interest due to ketamine's properties.
Purpose of the Study:
- To review the current role of ketamine in pediatric anesthesia.
- To examine recent findings on ketamine's efficacy and safety.
- To discuss the implications of ketamine's proapoptotic effects.
Main Methods:
- Literature review of ketamine's use in pediatric anesthesia.
- Analysis of recent studies on ketamine's effects in adults and rodents.
- Discussion of safety concerns and ongoing research.
Main Results:
- Ketamine effectively manages surgical and opioid-induced hyperalgesia in adults.
- It exhibits anti-inflammatory properties, potentially limiting surgical inflammation.
- Potential proapoptotic effects and long-term behavioral deficits in rodents raise safety concerns for pediatric use.
- Benefits in pediatric populations require further confirmation.
Conclusions:
- Ketamine's full interaction profile in humans is not yet understood.
- Recent research highlights both beneficial properties and potential adverse effects.
- Further research is crucial to determine ketamine's precise impact on pediatric neurodevelopment.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...